(No ratings)
Dr. Bertil Glader, MD is a pediatric oncologist in Palo Alto, CA specializing in pediatric hematology/oncology. Dr. Bertil Glader, MD is affiliated with Stanford Medicine Children's Health.
725 Welch Road
Palo Alto, CA 94304
Hemophilia
Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:
Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.
Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.
Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.
He completed residency at Boston Medical Center. He is certified by the Hematology, American Board of Pathology, Pediatric Hematology-Oncology, American Board of Pediatrics, Pediatrics, American Board of Pediatrics and has a state license in California.
Residency: Boston Medical Center (1973)
Board Certification: Hematology, American Board of Pathology, Pediatric Hematology-Oncology, American Board of Pediatrics, Pediatrics, American Board of Pediatrics (1983)
Licensed In: California
Dr. Bertil Glader, MD is associated with these hospitals and organizations:
Dr. Bertil Glader, MD does not have any reviews yet, be the first to leave a review of Dr. Bertil Glader, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Bertil Glader, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Agios Pharmaceuticals, Inc. |
$43,613
PYRUKYND $10,349 |
$33,264 |
---|---|---|
BioMarin Pharmaceutical Inc. |
$905
$905 |
|
Novo Nordisk Inc |
$323
Novoeight $65 |
$258 |
Spark Therapeutics, Inc. |
$249
$249 |
|
Alexion Pharmaceuticals, Inc. |
$122
ULTOMIRIS $122 |
|
Other |
$166
HEMLIBRA $116 |
Hemophilia - RECOMBINATE $50 |
Honoraria | $22,418 |
---|---|
Consulting Fee | $11,325 |
Education | $7,033 |
Travel and Lodging | $2,675 |
Food and Beverage | $1,927 |
Dr. Bertil Glader, MD has received 46 research payments totaling $279,728.
Dr. Bertil Glader specializes in pediatric hematology/oncology. He has indicated that his clinical interests include hemolytic anemia, aplastic anemia, and hemophilia. His medical residency was performed at Boston Medical Center and Children's Hospital Boston. Dr. Glader is professionally affiliated with Stanford Medicine Children's Health.